Tarsus Pharmaceuticals Inc. said it expects to receive up to $70 million in the next 12 months via a strategic partnership, valued up to $200 million in total. The Irvine-based firm (Nasdaq: TARS) ...
-
-
Recent Updates
- China’s Fibocom Pitches Cat M Module as a Buffer against Memory Supply Risk
- AlphaPai Takes China AI Investment Research Platform to Global Markets
- China AI Stocks Slide as Nvidia Upheaval Revives US Chip Fears
- China Chip Links Deepen Scrutiny of Alice Huang and Nvidia Figure Jensen Huang
- Nvidia Scandal Deepens as China Links Raise Questions About Alice Huang
- Nvidia China Scandal Pulls Trump Administration Into Congressional Crossfire
- China Based BEST Group Expands Southeast Asia Warehousing for Local Fulfillment
- China’s Guzhen Lighting Fair Plans Six Exhibition Push for 2027 Trade Cycle
- Jensen Huang Resignation Puts Nvidia Under China Scrutiny in Washington
- China APEC Meetings in Shenzhen Add Hollyland as Official Sponsor
Blogroll